MARAVAI LIFESCIENCES HLDGS-A (MRVI)

Company Profile

Maravai Lifesciences Holdings, Inc. is a life sciences company. The company is headquartered in San Diego, California and currently employs 670 full-time employees. The company went IPO on 2020-11-20. The firm provides products that enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The Company’s segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of modified nucleic acid products to support the needs of customers’ research, therapeutic and vaccine programs. This segment also provides research products for labeling and detecting proteins in cells and tissue samples. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company provides products that support its customers’ needs from discovery through commercialization of their vaccines, therapeutic agents and in vitro diagnostic products.

Company Info

MARAVAI LIFESCIENCES HLDGS-A

10770 Wateridge Circle Suite 200, Suite 200

San Diego CALIFORNIA 92121

P: 18585460004

CEO: Carl Hull

Employees: 670

Website: https://www.maravai.com/